Birchview Capital, LP - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$826,000
+66.9%
30,0000.0%0.49%
+68.0%
Q1 2021$495,000
-10.5%
30,0000.0%0.29%
-7.8%
Q4 2020$553,000
-32.2%
30,000
-50.0%
0.32%
+16.8%
Q3 2020$816,000
+51.7%
60,000
+100.0%
0.27%
-16.0%
Q2 2020$538,000
+79.9%
30,0000.0%0.32%
+22.6%
Q1 2020$299,00030,0000.26%
Other shareholders
TRANSLATE BIO INC shareholders Q2 2020
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders